Living with a chronic condition often means managing ongoing symptoms that don’t always respond well to traditional treatments. Many patients face treatment fatigue, feeling frustrated when prescribed medications don’t bring enough relief. In recent years, medical cannabis has emerged as a treatment option that some patients and doctors consider. But how exactly do specialist clinicians decide whether medical cannabis is appropriate? This article breaks down the key steps in that decision-making process, referencing NICE (National Institute for Health and Care Excellence) guidance and educational resources like Releaf to offer clear, patient-focused explanations.
Avoiding Confusion: Prescribed Medical Cannabis vs Shop-Bought CBD Oils
Before we dive deeper, it’s important to distinguish between prescribed medical cannabis and shop-bought CBD oils. Many people confusedly lump these products together, but they are very different:
- Prescribed medical cannabis is a treatment authorised and issued by a specialist clinician within the UK’s legal framework. Shop-bought CBD oils are widely available over the counter or online but are not prescribed, and their contents and quality can vary significantly.
Our focus here is only on prescribed medical cannabis and how specialists decide if it is the right treatment for you.
Understanding the Legal and Clinical Framework in the UK
In November 2018, the UK legalised prescribed cannabis-based products for medicinal use (CBPMs). However, the use is tightly controlled. The key points are:
- Only specialist clinicians (consultants in relevant fields) can prescribe medical cannabis. General practitioners (GPs) cannot initiate treatment but may continue prescriptions started by specialists. The prescribed products are usually unlicensed, meaning they do not have a UK marketing authorisation and are tailored to individual patients.
This approach ensures safety and careful consideration but also means that navigating the pathway to access can feel complex.
The Specialist-Led Decision: What Happens During Assessment?
When a specialist considers medical cannabis as a treatment option, the decision is comprehensive and based on clinical evidence, patient history, and individual risks and benefits. Here’s how they usually proceed:
1. Comprehensive Medical History Assessment
A detailed medical history is vital. The specialist needs to know:
- Your primary diagnosis and how it’s been managed so far. Current and past treatments, including prescribed medications and other therapies. Specific symptom patterns and severity. Any history of mental health conditions or substance misuse, which may affect suitability. Personal lifestyle factors and preferences.
This history gives context and helps identify if medical cannabis might address unmet needs.
2. Evaluate Benefits Versus Risks of Cannabis Treatment
Specialists weigh the potential advantages of medical cannabis against possible side effects and risks. NICE guidance emphasises this personalised risk-benefit analysis. Factors include:
- The likelihood of symptom relief (such as pain management or spasticity reduction). Potential side effects like dizziness, fatigue, or psychiatric effects. The risk of interactions with other medications you take. Long-term uncertainties since unlicensed cannabis products have limited large-scale trial data.
The goal is to avoid providing a treatment that causes more harm than good.
3. Reviewing Previous Treatments and Establishing Realistic Expectations
Medical cannabis is never seen as a miracle cure. Specialists check that you have tried standard and evidence-based treatments first. NICE guidance advises considering cannabis only after conventional approaches have failed or caused intolerable side effects.
At this stage, specialists discuss what you might realistically expect, addressing common misunderstandings such as “cannabis will cure me” or “it will instantly eliminate pain.” Setting clear, evidence-based goals helps manage hope and disappointment.
4. Deciding on the Right Product and Dosage
Since medical cannabis products are unlicensed, they come in varying formulations (such as THC-dominant or CBD-dominant). Specialists tailor prescribing based on the patient’s condition and response to treatment. They start with low doses and adjust cautiously. This process requires ongoing monitoring.
What Does NICE Say About Medical Cannabis?
The National Institute for Health and Care Excellence (NICE) is the UK's official health guidance body. Their recommendations reflect current evidence and aim to protect patient safety. Key NICE points about medical cannabis include:
- Restricting prescribing to specialist clinicians. Emphasising the importance of informed consent and clear communication on risks and benefits. Encouraging enrolment in registries or follow-up programs to track outcomes since evidence is still emerging.
You can read NICE's full guidance on their website.
Using Educational Resources Like Releaf
Releaf offers patient-focused information online, helping to explain medical cannabis in plain English. Their pages cover:
- How cannabis can affect different conditions. Clarifying common myths and realistic expectations. Patient experiences and practical tips.
Those starting medical cannabis treatment may find such resources helpful in understanding what to expect and how to discuss concerns with their specialists.
Common Mistakes to Avoid When Considering Medical Cannabis
One frequent mistake in articles and discussions is mentioning cannabis prices or costs without referencing official sources. Medical cannabis pricing varies depending on the product and supplier and is often not published openly by NHS or clinics. Since costs can be significant and vary, it’s best to discuss financial implications directly with your specialist or clinic.
Checklist: What to Ask Your Specialist When Medical Cannabis Is Discussed
What are the realistic benefits I can expect from medical cannabis? What are the possible side effects and risks? Have I tried all standard treatments first? How will the cannabis product be tailored to my condition? How often will I be monitored, and what does follow-up involve? What happens if the treatment doesn’t help or causes issues? Will this be prescribed by a specialist and follow NICE guidance? What support and education resources are available for me?Summary Table: Key Points in Specialist-Led Decision Making
Step Description Key Considerations Medical History Assessment Gather detailed patient condition and treatment background Symptom severity, prior therapies, mental health, lifestyle Risk vs Benefits Analysis Evaluate potential outcomes and side effects Symptom relief likelihood, side effect profile, drug interactions Treatment History Review Ensure standard treatments attempted and guide expectations Evidence-based prior treatments, managing hopes Product Selection and Dosage Decide on suitable unlicensed cannabis product and dosing Tailoring THC/CBD ratios, low starting dose, ongoing review Informed Consent and Follow-up Ensure patient understanding and plan monitoring Clear communication, enrolment in registries, safety checksFinal Thoughts
Prescribed medical cannabis offers a more info new, specialist-led treatment option for some people living with chronic conditions that have proved difficult to manage with conventional therapies. However, it is important to approach it with informed caution. The decision rests on a thorough medical history assessment, a careful weighing of benefits versus risks, and the clear involvement of a specialist clinician following NICE guidance.
If you’re considering medical cannabis, speak openly with your specialist. Ask questions, seek information from trustworthy sources like NICE and Releaf, and prepare for a personalised, closely monitored treatment approach. Remember, medical cannabis is not a medical cannabis for arthritis UK cure-all, but for some, it might provide meaningful symptom relief when nothing else has.